Medical Devices

Philips (NYSE: PHG) announced today it has reinforced its strategic alliance with Sim&Cure. Known for their cutting-edge digital approaches in neurovascular therapies, Sim&Cure initially partnered with Philips, which is based in Amsterdam, five years ago. Now, they are embarking on […]

Johnson & Johnson MedTech has announced an important milestone: the FDA has extended approval for use of Impella heart pumps in treating certain pediatric patients. The approval expansion includes the use of the Impella 5.5 with SmartAssist and the Impella

Bausch + Lomb announced today that it has begun considering the possibility of a sale following a request from regulatory authorities. The eye care company, headquartered in Vaughan, Ontario, was prompted by the Canadian Investment Regulatory Organization (CIRO) due to

Masimo, listed on Nasdaq as MASI, revealed plans to cut 75 positions at its headquarters in Irvine, California. These job reductions, impacting many engineers and designers, are slated to be permanent and will take effect on January 13, 2025. This

FemPulse revealed today that it has secured IDE (Investigational Device Exemption) approval from the FDA for its treatment targeting overactive bladder (OAB). This paves the way for the initiation of the EVANESCE II pivotal clinical trial focusing on female patients

Bausch + Lomb has revealed that its subsidiary has completed the acquisition of Elios Vision, a pioneer in minimally invasive glaucoma surgery (MIGS) techniques. The Elios technique utilizes an excimer laser during cataract surgeries to manage glaucoma without requiring any

Karl Storz U.S. has rolled out Pathway.AI, a novel tool in collaboration with Artisight, within the United States. Artisight’s smart hospital platform supports the AI tool that is crafted to detect and address changes in the operating room (OR) status.

Theradaptive recently disclosed that it has obtained FDA authorization to expand its study on OsteoAdapt SP. This enlarged trial incorporates three types of spinal fusion indications and will increase the number of investigational locations in the U.S. threefold. Earlier this

Augmedics has recently appointed Paul Ziegler as its new CEO and president. In light of this leadership change, Gwen Watanabe is set to shift from her interim CEO role to serve as vice chair on the board. Watanabe served in

Capstan Medical has successfully secured $110 million through a highly sought-after Series C funding round, as announced by the company today. Specializing in structural heart surgical robots, Capstan Medical plans to use this influx of funds to prepare for its